As of September 2024 Elite Pharmaceuticals has 1.01B shares outstanding, a increase of 0.23% from 2023. It represents the total number of shares of a company that are owned by all its shareholders, including both public investors and company insiders.
Year | Shares outstanding | Change |
---|---|---|
2023 | 1.01B | 0.23% |
2022 | 1.01B | 7.17% |
2021 | 943.00M | 13.30% |
2020 | 832.33M | - |